Pharmaceutical manufacturer for Topical formulation development

AbbVie Contract Manufacturing boasts more than three decades of expertise in AbbVie's manufacturing sector. Operating as an integrated CMO, it harnesses extensive knowledge, cooperation, and state-of-the-art facilities, delivering comprehensive services to customers across various domains such as development, production, compliance, and marketing, while ensuring adherence to the highest international benchmarks. Additionally, AbbVie Contract Manufacturing aids clients in streamlining manufacturing, optimizing supply networks, expediting time-to-market, ensuring adherence to regulations, and providing unparalleled quality.

Quotient Sciences operates as an accelerator for drug development and manufacturing, offering comprehensive services throughout the entire development process for small molecules and peptide drug programs. We break down barriers across various drug development capabilities, ultimately saving valuable time and resources in bringing medications to patients

Aurigene Pharmaceutical Services is a contract research organization/contract development and manufacturing organization with more than twenty years of expertise. It provides a variety of services for novel therapeutics, ranging from drug exploration, clinical investigation and advancement to producing APIs and formulations at industrial scales. It possesses research laboratories from discovery to clinical phase 3 and cGMP manufacturing facilities in the United Kingdom, Mexico, the United States, and India. Its technological platforms encompass cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides, and oligonucleotides. Its extensive molecule exploration services include antibody-drug conjugates, monoclonal antibodies, messenger RNA, and chimeric antigen receptor T-cell therapy. Aurigene's two research and development centers are inspected by the United States Food and Drug Administration.

TriRx Pharmaceutical Services is an international provider of contract development and manufacturing services (CDMO) for the biopharmaceutical, pharmaceutical, and animal health sectors. Its headquarters are situated around 50 miles from New York City in Norwalk, Connecticut. TriRx operates modern laboratory, manufacturing, packaging, warehousing, and technical service facilities across various regions. It was established by a group of executives from the pharmaceutical industry, who have experience as both service providers and customers. TriRx differentiates itself by prioritizing honesty, transparency, and integrity, aiming to be a dependable long-term supply partner and product steward for its customers.

Mission CDMO provides a complete range of contract services at our FDA-approved, cGMP compliant site situated on our expansive Boerne, Texas campus. Our proficient team is committed to delivering tailored solutions to fulfill your product and partnership requirements. Let us bring your product from concept to commercialization by establishing a partnership that brings your vision to life and surpasses your anticipations. Mission CDMO produces high-quality prescription drug products, non-prescription drug products, and nutritional supplements for our company and our clientele at our FDA-approved, cGMP compliant facility.

Novick provides an array of services including the development and manufacturing of Complex Generics, 505b2, and NDAs of the Solid, Liquid oral dose, Injectables, Creams, and Gel products, as well as Discovery Chemistry research, development, and manufacturing services (CRAMS - Milligram to Multi-kilo). As a rapidly-expanding Contract Research and Development Organization (CRDO), Novick Bio-Sciences delivers chemistry and formulation development services to Global Pharmaceutical, Bio-tech, Agrochemical Research Organizations, and Academics, aiming to assist customers in achieving their objectives. The company is dedicated to offering top-notch products at competitive prices in a timely manner, ensuring that scientists and researchers have the necessary research tools for today's competitive landscape.

Amarin Technologies S.A. (Amarin) operates as a well-established Argentinean company located in Buenos Aires, Argentina, focusing specifically on the development of topical and transdermal pharmaceutical products through the utilization of proprietary drug delivery technologies and expertise. The R&D team of Amarin has been active since the early 1986 and has successfully brought innovative formulations and generic versions of well-established drugs to various markets worldwide, including EU, Latam and the US (Fentanyl, Rivastigmine, Buprenorphine, and Diclofenac). Helm AG, a Hamburg-based company, became a strategic shareholder in Amarin in September 2010.